These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9721766)

  • 1. Levonorgestrel capsule implants in the United States: a 5-year study.
    Sivin I; Mishell DR; Darney P; Wan L; Christ M
    Obstet Gynecol; 1998 Sep; 92(3):337-44. PubMed ID: 9721766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study.
    Sivin I; Campodonico I; Kiriwat O; Holma P; Diaz S; Wan L; Biswas A; Viegas O; el din Abdalla K; Anant MP; Pavez M; Stern J
    Hum Reprod; 1998 Dec; 13(12):3371-8. PubMed ID: 9886517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contraception with two levonorgestrel rod implants. A 5-year study in the United States and Dominican Republic.
    Sivin I; Alvarez F; Mishell DR; Darney P; Wan L; Brache V; Lacarra M; Klaisle C; Stern J
    Contraception; 1998 Nov; 58(5):275-82. PubMed ID: 9883382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
    Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
    Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 5-year clinical evaluation of Norplant implants in Senegal.
    Ba MG; Moreau JC; Sokal D; Dunson R; Dao B; Kouedou D; Diadhiou F
    Contraception; 1999 Jun; 59(6):377-81. PubMed ID: 10518232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
    Sivin I
    Drug Saf; 2003; 26(5):303-35. PubMed ID: 12650633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability.
    Coukell AJ; Balfour JA
    Drugs; 1998 Jun; 55(6):861-87. PubMed ID: 9617600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
    Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
    Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 5-year evaluation of NORPLANT contraceptive implants in China.
    Gu SJ; Du MK; Zhang LD; Liu YL; Wang SH; Sivin I
    Obstet Gynecol; 1994 May; 83(5 Pt 1):673-8. PubMed ID: 8164924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
    McNicholas C; Swor E; Wan L; Peipert JF
    Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and continuation rates of Norplant in Pakistan.
    Rehan N; Inayatullah A; Chaudhary I
    Contraception; 1999 Jul; 60(1):39-43. PubMed ID: 10549451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical performance of a new two-rod levonorgestrel contraceptive implant: a three-year randomized study with Norplant implants as controls.
    Sivin I; Viegas O; Campodonico I; Diaz S; Pavez M; Wan L; Koetsawang S; Kiriwat O; Anant MP; Holma P; el din Abdalla K; Stern J
    Contraception; 1997 Feb; 55(2):73-80. PubMed ID: 9071515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NORPLANT contraceptive implants advancing.
    Segal SJ
    Netw Res Triangle Park N C; 1984; 5(3):1-3. PubMed ID: 12279797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experience with 7 years of norplant].
    Huang S; Gu S
    Zhonghua Fu Chan Ke Za Zhi; 1999 Nov; 34(11):674-6. PubMed ID: 11479951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuation rates with a levonorgestrel-releasing contraceptive implant (Norplant). A prospective study in Belgium.
    Vekemans M; Delvigne A; Paesmans M
    Contraception; 1997 Nov; 56(5):291-9. PubMed ID: 9437557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged effectiveness of Norplant(R) capsule implants: a 7-year study.
    Sivin I; Mishell DR; Diaz S; Biswas A; Alvarez F; Darney P; Holma P; Wan L; Brache V; Kiriwat O; Abdalla K; Campodonico I; Pasquale S; Pavez M; Schechter J
    Contraception; 2000 Mar; 61(3):187-94. PubMed ID: 10827332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal implants: contraception for a new century.
    Darney PD
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subdermal levonorgestrel implants. Three years' experience in Cairo, Egypt.
    Rizk DE
    J Reprod Med; 1995 Sep; 40(9):638-44. PubMed ID: 8576880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implant contraception in Singaporean women: one decade of experience in KK Women's and Children's Hospital.
    Kang W; Tan KH
    Singapore Med J; 2004 Oct; 45(10):482-6. PubMed ID: 15455169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.